老年胆总管结石ERCP术后高淀粉酶血症危险因素及预测模型
Risk Factors and Predictive Model for Post-ERCP Hyperamylasemia in Elderly Choledocholithiasis Patients
DOI: 10.12677/ACM.2023.13122711, PDF,    科研立项经费支持
作者: 张文姣:青岛大学医学部,山东 青岛;张巍巍, 付来琳, 刘静依, 郝明星, 解祥军*:青岛市市立医院,消化内科,山东 青岛;谢方瑜:青岛市市立医院,心内科,山东 青岛;于 江:青岛市市立医院,肝胆胰外科,山东 青岛;陈丽丽:青岛市市立医院,内窥镜室,山东 青岛
关键词: 老年人胆总管结石ERCP高淀粉酶血症预测模型Aged Choledocholithiasis ERCP Hyperamylasemia Predictive Model
摘要: 目的:探讨老年胆总管结石内镜逆行胰胆管造影术(ERCP)治疗术后发生高淀粉酶血症的主要危险因素并构建相关预测模型。方法:收取2021年1月至2023年2月青岛市市立医院收治经ERCP取石术治疗的老年胆总管结石患者共227例,根据术后血淀粉酶结果分为高淀粉酶血症组与正常组,通过x2检验及logistic回归分析分析其危险因素,构建并检验预测模型。结果:logistic回归分析结果显示超高龄,内镜下乳头柱状气囊扩张术(EPBD)等为高淀粉酶血症的危险因素(P < 0.05, OR > 1),内镜下鼻胆管引流术(ENBD)等为保护因素(P < 0.05, OR < 1)。列线图预测模型受试者工作特征曲线下面积为0.829,模型对ERCP术后高淀粉酶血症具有良好的预测能力。结论:ERCP取石术后危险因素分析为临床预防、减少术后高淀粉血症的发生有着重要意义。列线图风险预测模型预测效能良好,为老年性胆总管结石ERCP取石术后高淀粉酶血症预测提供了依据。
Abstract: Objective: To investigate the primary clinical risk factors of hyperamylasemia after endoscopic ret-rograde cholangiopancreatography (ERCP) in elderly patients with choledocholithiasis and to con-struct a related prediction model. Methods: A total of 227 elderly patients with choledocholithiasis treated by ERCP in Qingdao Municipal Hospital from January 2021 to February 2023 were enrolled. Based on postoperative amylase levels, patients were divided into the hyperamylasemia group and the normal group. The risk factors were analyzed by χ2 test and logistic regression analysis, and the prediction model was constructed and tested. Results: Logistic regression analysis revealed that advanced age, endoscopic papillary balloon dilation (EPBD), and other factors were associated with hyperamylasemia (P < 0.05, OR > 1), while endoscopic nasobiliary drainage (ENBD) and other fac-tors were protective (P < 0.05, OR < 1). The receiver operating characteristic curve for the predic-tive model had an area under the curve of 0.829, indicating its good predictive capability for post-ERCP hyperamylasemia. Conclusion: Analyzing the risk factors for post-ERCP hyperamylasemia is crucial for clinical prevention and reduction of this complication. The predictive model based on logistic regression demonstrates good predictive performance and provides a foundation for pre-dicting hyperamylasemia in elderly patients with common bile duct stones following ERCP stone removal procedures.
文章引用:张文姣, 张巍巍, 付来琳, 谢方瑜, 于江, 陈丽丽, 刘静依, 郝明星, 解祥军. 老年胆总管结石ERCP术后高淀粉酶血症危险因素及预测模型[J]. 临床医学进展, 2023, 13(12): 19255-19264. https://doi.org/10.12677/ACM.2023.13122711

参考文献

[1] Manes, G., Paspatis, G., Aabakken, L., et al. (2019) Endoscopic Management of Common Bile Duct Stones: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 51, 472-491. [Google Scholar] [CrossRef] [PubMed]
[2] Dumonceau, J.M., Kapral, C., Aabakken, L., et al. (2020) ERCP-Related Adverse Events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 52, 127-149. [Google Scholar] [CrossRef] [PubMed]
[3] 潘宏伟, 王晨, 张艳. 经内镜逆行胰胆管造影术后并发胰腺炎和高淀粉酶血症的危险因素分析[J]. 中国内镜杂志, 2018, 24(7): 26-32.
[4] Shih, H.Y., Hsu, W.H. and Kuo, C.H. (2019) Postendoscopic Retrograde Cholangiopancreatography Pancreatitis. The Kaohsiung Journal of Medical Sciences, 35, 195-201. [Google Scholar] [CrossRef] [PubMed]
[5] Matsubayashi, C.O., Ribeiro, I.B., de Moura, et al. (2020) Is Endoscopic Balloon Dilation Still Associated with Higher Rates of Pancreatitis? A Systematic Review and Meta-Analysis. Pancreas, 49, 158-174. [Google Scholar] [CrossRef
[6] Fujisawa, T., Kagawa, K., Hisatomi, K., et al. (2016) Is Endoscopic Papillary Balloon Dilatation Really a Risk Factor for Post-ERCP Pancreatitis? World Journal of Gastroen-terology, 22, 5909-5916. [Google Scholar] [CrossRef] [PubMed]
[7] Dubravcsik, Z., Hritz, I., Szepes, A., et al. (2020) Risk Factors of Post-ERCP Pancreatitis in High-Risk Patients despite Prevention with Prophylactic Pancreatic Stents. Scandinavian Journal of Gastroenterology, 55, 95-99. [Google Scholar] [CrossRef] [PubMed]
[8] 周巧直, 刘天宇, 隗永秋, 等. 胰管支架置入在预防内镜逆行性胰胆管造影术后急性胰腺炎发生中的作用[J]. 中华预防医学杂志, 2022, 56(7): 990-993.
[9] Avila, P., Holmes, I., Kouanda, A., et al. (2020) Practice Patterns of Post-ERCP Pancreatitis Prophylaxis Techniques in the United States: A Survey of Advanced Endoscopists. Gastrointestinal Endoscopy, 91, 568-573.e2. [Google Scholar] [CrossRef] [PubMed]
[10] 张诚, 杨玉龙, 何川琦. 胰管支架置入联合生长抑素预防内镜逆行胰胆管造影术后急性胰腺炎的疗效评价[J]. 中华医学杂志, 2021, 101(4): 276-279.
[11] Li, L., Liu, M., Zhang, T., et al. (2019) Indomethacin Down-Regulating HMGB1 and TNF-α to Prevent Pancreatitis after Endoscopic Retro-grade Cholangiopancreatography. Scandinavian Journal of Gastroenterology, 54, 793-799. [Google Scholar] [CrossRef] [PubMed]
[12] 中华医学会消化内镜学分会ERCP学组, 中国医师协会消化医师分会胆胰学组, 国家消化系统疾病临床医学研究中心. 中国ERCP指南(2018版) [J]. 中华消化内镜杂志, 2018, 35(11): 777-813.
[13] Akshintala, V.S., Sperna Weiland, C.J., Bhullar, F.A., et al. (2021) Non-Steroidal An-ti-Inflammatory Drugs, Intravenous Fluids, Pancreatic Stents, or Their Combinations for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Network Meta-Analysis. The Lancet Gastroenterology and Hepatology, 6, 733-742. [Google Scholar] [CrossRef
[14] Fogel, E.L., Lehman, G.A., Tarnasky, P., et al. (2020) Rectal Indometacin Dose Escalation for Prevention of Pancreatitis after Endoscopic Retrograde Cholangiopancreatography in High-Risk Patients: A Double-Blind, Randomised Controlled Trial. The Lancet Gastroenterology and Hepatology, 5, 132-141. [Google Scholar] [CrossRef
[15] 蔡宇, 邱新平, 张宁宁, 等. 生长抑素和奥曲肽分别与乌司他汀联用对重症急性胰腺炎大鼠胰腺组织损伤及免疫指标的影响比较[J]. 临床和实验医学杂志, 2021, 20(10): 1039-1042.
[16] Serrano, J.P.R., Jukemura, J., Romanini, S.G., et al. (2020) Nonsteroidal Anti-Inflammatory Drug Ef-fectivity in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-Analysis. World Journal of Gastrointestinal Endoscopy, 12, 469-487. [Google Scholar] [CrossRef] [PubMed]
[17] 蒋鹏, 苏树英, 费凛, 等. 吲哚美辛联合生长抑素预防ERCP术后胰腺炎[J]. 肝胆胰外科杂志, 2019, 31(4): 217-220+232.
[18] 沙志虎, 顾伟刚, 金杭斌, 等. 胰管支架联合吲哚美辛栓对困难胆管插管术后胰腺炎的预防作用分析[J]. 中华消化内镜杂志, 2023, 40(4): 302-307.
[19] 何远, 黄秋梅, 梁志海. Lemmel综合征一例[J]. 中华消化病与影像杂志(电子版), 2021, 11(1): 43-44.
[20] Tabak, F., Wang, H.S., Li, Q.P., et al. (2020) Endoscopic Retrograde Cholangiopancreatography in Elderly Patients: Difficult Cannulation and Adverse Events. World Journal of Clinical Cases, 8, 2988-2999. [Google Scholar] [CrossRef] [PubMed]
[21] Mutneja, H.R., Vohra, I., Go, A., et al. (2021) Temporal Trends and Mortality of Post-ERCP Pancreatitis in the United States: A Nationwide Analysis. Endoscopy, 53, 357-366. [Google Scholar] [CrossRef] [PubMed]
[22] 马敏, 周中银. 经内镜逆行胰胆管造影术后急性胰腺炎与高淀粉酶血症对比观察[J]. 临床肝胆病杂志, 2020, 36(2): 395-398.